# Leukemia, Myeloid, Acute trials, no drug phase: 69 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 69 trials with no drug phase for Leukemia, Myeloid, Acute that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Leukemia, Myeloid, Acute trials with no drug phase: 69 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/leukemia-myeloid-acute

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 69
- Recruiting or not yet: 69
- Read on: November 19, 2026

## Trials

The 25 newest of 69, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07912684 | The Value of a Tailored-based, Exercise Program for Improving Quality of Life of Patients With Hematologic Malignancies: a Pilot Randomized... | Gruppo Italiano Malattie EMatologiche dell'Adulto | Not applicable | Recruiting | Acute Myeloid Leukemia, Multiple Myeloma, Lymphoma | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912684) |
| October 29, 2026 | NCT07904884 | MAC vs RIC for Transplantation in FLT3-ITD-Mutated AML Guided by UHS-NGS MRD ( FLT3 - MAC vs RIC ) | First Affiliated Hospital of Zhejiang University | Not applicable | Not yet recruiting | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia | 310 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904884) |
| October 14, 2026 | NCT07874100 | This Study Aims to Improve the Stratification of Patients With Acute Myeloid Leukemia to Enable More Personalized and Effective Treatments... | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Not applicable | Recruiting | Acute Myeloid Leukemia | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874100) |
| October 9, 2026 | NCT07869342 | NAC for Hematopoietic Recovery in Low/Intermediate-Risk AML After CR: A Randomized Controlled Study | Peking University People's Hospital | Not applicable | Not yet recruiting | Acute Myeloid Leukemia, Adult | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869342) |
| October 9, 2026 | NCT07867704 | Feasibility and Efficiency Study for the Implementation of a New Screening Method for Patients With Acute Myeloid Leukemia, in Laboratory... | Gruppo Italiano Malattie EMatologiche dell'Adulto | Not applicable | Not yet recruiting | Acute Myeloid Leukemia, Acute Myeloid Leukemia, Adult, Acute Promyelocytic Leukemia | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867704) |
| September 9, 2026 | NCT07809984 | Prevention of Oral Mucositis in Adults in With Hematologic Malignancy | Wake Forest University Health Sciences | Not applicable | Not yet recruiting | Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Oral Mucositis | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07809984) |
| September 4, 2026 | NCT07805096 | Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual Health | National Defense Medical University, Taiwan | Not applicable | Recruiting | Leukemia (Both ALL and AML), Brain Tumors | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805096) |
| August 20, 2026 | NCT07777471 | Improving Delivery of Aging-Related Supportive Care for Older Adults With Acute Myeloid Leukemia | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Acute Myeloid Leukemia (AML) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777471) |
| August 13, 2026 | NCT07762508 | A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients | The First Affiliated Hospital of Soochow University | Not applicable | Not yet recruiting | Leukemia, Myeloid, Acute(AML), Hematopoietic Stem Cell Transplantation (HSCT) | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762508) |
| July 17, 2026 | NCT07710781 | Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic... | Ossium Health, Inc. | Not applicable | Not yet recruiting | Hematologic Malignancy, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710781) |
| June 12, 2026 | NCT07644481 | Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem... | Institute of Hematology & Blood Diseases Hospital, China | Not applicable | Not yet recruiting | AML (Acute Myelogenous Leukemia), Allogeneic Hematopoietic Stem Cell Transplantation Recipient | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07644481) |
| June 1, 2026 | NCT07616921 | A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia... | University of Washington | Not applicable | Recruiting | Acute Myeloid Leukemia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616921) |
| May 19, 2026 | NCT07597590 | Digital Patient-Reported Assessment in Older Adults With Acute Leukemia | Fundación para la Investigación Biosanitaria del Principado de Asturias | Not applicable | Not yet recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07597590) |
| May 14, 2026 | NCT07588360 | Haplo-Cord HSCT for AML/MDS | Fujian Medical University Union Hospital | Not applicable | Recruiting | MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia) | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588360) |
| May 4, 2026 | NCT07563920 | TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Not applicable | Not yet recruiting | Acute Myeloid Leukemia | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563920) |
| April 9, 2026 | NCT07521124 | ABC Maintenance Therapy for AML | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not applicable | Not yet recruiting | Acute Myeloid Leukemia (AML) in Remission | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07521124) |
| April 8, 2026 | NCT07516353 | my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults | Dana-Farber Cancer Institute | Not applicable | Not yet recruiting | Sarcoma, Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma, Acute Myeloid Leukemia, Aml, ALL, Medulloblastoma, Acute... | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07516353) |
| March 30, 2026 | NCT07500753 | A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients | The First Affiliated Hospital of Soochow University | Not applicable | Recruiting | Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07500753) |
| March 13, 2026 | NCT07469592 | eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation | University of Miami | Not applicable | Recruiting | Stem Cell Transplantation, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic... | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07469592) |
| February 4, 2026 | NCT07386392 | Effect of Hypnosis and Virtual Reality on Anxiety During Treatment for Acute Myeloid Leukemia | University Hospital, Toulouse | Not applicable | Not yet recruiting | Acute Myeloid Leukemia | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07386392) |
| January 15, 2026 | NCT07342244 | Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | AML, AML (Acute Myeloid Leukemia) | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07342244) |
| January 9, 2026 | NCT07328191 | Quality of Life-Guided Transfusion in Refractory MDS or AML | Centre Hospitalier Universitaire de Nice | Not applicable | Recruiting | MDS, AML, Adult, Anemia | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07328191) |
| January 6, 2026 | NCT07319793 | Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT | Peking University People's Hospital | Not applicable | Not yet recruiting | Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07319793) |
| December 22, 2025 | NCT07297576 | Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation | Institute of Hematology & Blood Diseases Hospital, China | Not applicable | Recruiting | ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia, MDS (Myelodysplastic Syndrome) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297576) |
| November 26, 2025 | NCT07250217 | Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients | Groupe Hospitalier de la Region de Mulhouse et Sud Alsace | Not applicable | Recruiting | Acute Myeloblastic Leukemia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07250217) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| The First Affiliated Hospital of Soochow University | 5 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 4 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Peking University People's Hospital | 3 |
| University of Washington | 2 |
| Sohag University | 2 |
| University of Rochester | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Massachusetts General Hospital | 2 |
| Ruijin Hospital | 2 |
| Institut Claudius Regaud | 2 |
| Wake Forest University Health Sciences | 2 |
| Children's Hospital of Philadelphia | 2 |
| First Affiliated Hospital of Zhejiang University | 2 |
| National Defense Medical University, Taiwan | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Thomas Jefferson University | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| Washington University School of Medicine | 1 |
| Dana-Farber Cancer Institute | 1 |
| Huai'an First People's Hospital | 1 |
| Fujian Medical University Union Hospital | 1 |
| Centre Leon Berard | 1 |
| Guangdong Provincial People's Hospital | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 24 |
| United States | 16 |
| France | 8 |
| Italy | 6 |
| Egypt | 2 |
| Taiwan | 1 |
| Belgium | 1 |
| Switzerland | 1 |
| Portugal | 1 |
| Denmark | 1 |
| Turkey (Türkiye) | 1 |
| Spain | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Plastic and reconstructive surgery practices in the United States](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/united-states)
- [Carpet installation companies in the United States](https://specstream.ai/data/businesses/carpet-installation-companies/united-states)
- [Orthopedic surgery practices in the United States](https://specstream.ai/data/businesses/orthopedic-surgery-practices/united-states)
- [Beverage suppliers in the United States](https://specstream.ai/data/businesses/beverage-suppliers/united-states)
- [Medical transportation companies in the United States](https://specstream.ai/data/businesses/medical-transportation-companies/united-states)
- [B2B industrial and machine companies in the United States](https://specstream.ai/data/businesses/b2b-industrial-and-machine-companies/united-states)
